What this quiz covers
This quiz focuses on Translation, giving you a quick way to practice the rules, question types, and explanations that matter most for AP Biology.
During translation, a ribosome begins at a start codon and reads an mRNA 5′→3′ in sets of three nucleotides. A student compares two mRNAs that are identical except at codon 4: mRNA 1 has 5′-AUG GCU UAC GAA CCG-3′, and mRNA 2 has 5′-AUG GCU UAC UAA CCG-3′. In this system, UAA is a stop codon recognized by a release factor rather than a tRNA. All other codons shown are sense codons that recruit tRNAs carrying amino acids. Which outcome is most likely for translation of mRNA 2 compared with mRNA 1?
AP Biology Quiz
Practice Translation in AP Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on Translation, giving you a quick way to practice the rules, question types, and explanations that matter most for AP Biology.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
During translation, a ribosome begins at a start codon and reads an mRNA 5′→3′ in sets of three nucleotides. A student compares two mRNAs that are identical except at codon 4: mRNA 1 has 5′-AUG GCU UAC GAA CCG-3′, and mRNA 2 has 5′-AUG GCU UAC UAA CCG-3′. In this system, UAA is a stop codon recognized by a release factor rather than a tRNA. All other codons shown are sense codons that recruit tRNAs carrying amino acids. Which outcome is most likely for translation of mRNA 2 compared with mRNA 1?
Explanation: This question tests your ability to analyze how stop codons affect translation outcomes. In mRNA 2, codon 4 changes from GAA (which codes for glutamate) to UAA, which is a stop codon that recruits release factors instead of tRNAs. When the ribosome encounters UAA at codon 4, the release factor binds and triggers termination, producing a polypeptide containing only the amino acids from codons 1-3 (Met-Ala-Tyr). Students choosing B incorrectly think ribosomes can skip stop codons, but release factors specifically recognize stop codons and cause termination. To solve translation problems, identify stop codons (UAA, UAG, UGA) and remember they always trigger termination when encountered.
During translation, a ribosome begins at the start codon and reads mRNA in groups of three nucleotides (codons). A student provides an mRNA segment: 5′-AUG GCU UAC GAA UGA-3′. The tRNA carrying methionine binds the start codon, and each subsequent codon is matched by a tRNA with a complementary anticodon, adding one amino acid per codon. Translation ends when a stop codon enters the ribosome, and no tRNA binds that codon. Assume this segment is in-frame and is translated without skipping or editing. Which outcome is most likely for the polypeptide produced from this mRNA segment?
Explanation: This question assesses the skill of analyzing translation by interpreting an mRNA sequence to determine the resulting polypeptide. The ribosome initiates at the start codon AUG, which codes for methionine, and then reads subsequent codons GCU (alanine), UAC (tyrosine), and GAA (glutamic acid), adding each corresponding amino acid to the growing chain. Translation proceeds until the stop codon UGA enters the ribosome, at which point no tRNA binds, and the polypeptide is released without adding an amino acid for the stop codon. Thus, the mRNA segment produces a polypeptide with four amino acids: methionine-alanine-tyrosine-glutamic acid. A tempting distractor is B, which claims a five-amino-acid polypeptide because UGA codes for a final amino acid, but this is incorrect due to the misconception that stop codons encode amino acids rather than signaling termination. To solve similar problems, always count the number of codons from the start codon up to but not including the stop codon, as stop codons do not add amino acids.
A student analyzes two mRNAs translated in the same cytosol. Both contain the same start codon and the same stop codon positions, but one has a single-base substitution that changes one codon to a different codon. The student is told that the new codon is recognized by a different tRNA carrying a different amino acid, and no other codons change. The ribosome reads codons sequentially and adds amino acids to the C-terminus of the growing chain. Which outcome is most likely for the mutant polypeptide compared with the original?
Explanation: This question assesses the skill of analyzing translation by examining the impact of a missense mutation on the polypeptide sequence. The single-base substitution changes one codon to another that codes for a different amino acid, but it does not alter the reading frame or the positions of the start and stop codons. The ribosome translates the mRNAs sequentially, incorporating the altered amino acid only at the position of the mutated codon, while all other amino acids remain the same. Thus, the mutant polypeptide differs by a single amino acid substitution at that specific position compared to the original. A tempting distractor is B, which states all downstream amino acids change due to a reading frame shift, but this is incorrect due to the misconception that nucleotide substitutions cause frameshifts like insertions or deletions do. When analyzing point mutations, use a codon table to check if the change affects only one codon and amino acid, without shifting the frame for subsequent codons.
During translation, the ribosome moves along mRNA in the 5′ to 3′ direction, decoding each codon in order. A researcher introduces an mRNA in which the start codon AUG is unchanged, but the stop codon is mutated to a sense codon that is recognized by a tRNA. The mRNA sequence downstream contains additional codons before a later stop codon. Assume initiation occurs normally and the ribosome remains bound to the mRNA. Which outcome is most likely for the translated product compared with the original mRNA?
Explanation: This question assesses the skill of analyzing translation by predicting the effect of mutating a stop codon to a sense codon on polypeptide length. Mutating the stop codon to a sense codon allows a tRNA to bind and add an amino acid at that position, preventing normal termination. The ribosome continues translating downstream codons until it reaches the next in-frame stop codon further along the mRNA. As a result, the translated product is a longer polypeptide incorporating additional amino acids beyond the original termination site. A tempting distractor is B, which claims a shorter polypeptide because the mutation prevents initiation at AUG, but this is incorrect due to the misconception that downstream mutations affect upstream initiation rather than only elongation and termination. To evaluate similar mutations, trace the translation path from the unchanged start codon and note how changes in stop signals extend or shorten the coding sequence.
Translation requires that the ribosome maintain a reading frame, grouping nucleotides into codons from the start codon. A wild-type mRNA segment is 5′-AUG AAA CCG UUU GGA UAA-3′. In a mutant, a single nucleotide is inserted immediately after the start codon, producing 5′-AUG UAAA ACC GUU UGG AUAA-3′ when regrouped from the same start site. Assume the ribosome initiates at AUG in both cases and continues until it encounters the first in-frame stop codon. Which outcome is most likely for the mutant compared with the wild type?
Explanation: This question assesses the skill of analyzing translation by evaluating the impact of a frameshift mutation on the reading frame and polypeptide sequence. The insertion of a single nucleotide after the start codon shifts the grouping of all downstream nucleotides into codons, changing the sequence from the wild-type AUG-AAA-CCG-UUU-GGA-UAA to the mutant AUG-UAA-AAC-CGU-UUG-GAU-AA in the provided regrouping. This frameshift alters the amino acids specified by the new codons and may change when the ribosome encounters an in-frame stop codon, resulting in a different polypeptide. Consequently, the mutant polypeptide differs from the wild-type due to the shifted reading frame affecting all codons after the insertion point. A tempting distractor is A, which states the polypeptide is identical because ribosomes remove inserted nucleotides, but this is incorrect due to the misconception that ribosomes edit mRNA during translation rather than reading it as is. To approach similar mutation problems, redraw the codon groupings starting from the start codon to visualize how insertions or deletions shift the frame and alter the sequence.
A scientist tests a drug that prevents the large ribosomal subunit from catalyzing peptide bond formation but does not prevent tRNA anticodons from pairing with mRNA codons. In treated cells, initiation still occurs at the start codon, and tRNAs can enter the ribosome according to codon-anticodon complementarity. However, the growing polypeptide cannot be transferred to the incoming aminoacyl-tRNA. Assume mRNA levels and transcription are unchanged. Which outcome is most likely in treated cells compared with untreated cells?
Explanation: This question assesses the skill of analyzing translation by predicting the consequences of inhibiting peptide bond formation during elongation. The drug blocks the large ribosomal subunit's peptidyl transferase activity, preventing the transfer of the growing polypeptide to the incoming aminoacyl-tRNA despite codon-anticodon pairing. Although initiation and tRNA binding can occur, the chain cannot grow beyond the initial amino acid, leading to stalled ribosomes and short peptide fragments. In treated cells, full-length polypeptides cannot form, resulting in a failure to produce functional proteins compared to untreated cells. A tempting distractor is D, which claims normal-length polypeptides form because codon-anticodon pairing creates covalent links, but this is wrong due to the misconception that base pairing alone forms peptide bonds without ribosomal catalysis. To evaluate similar inhibitor effects, identify which step of translation is blocked and trace how it halts the process, preventing downstream outcomes like chain elongation.
Two mRNAs differ at a single codon within an otherwise identical coding sequence. At position 5, mRNA X contains a codon that is recognized by a specific tRNA carrying amino acid M, while mRNA Y contains a different codon recognized by a different tRNA carrying amino acid N. Neither codon is a stop codon, and initiation occurs at the same start codon for both mRNAs. All translation components are present. Which outcome is most likely when comparing the polypeptides produced?
Explanation: This question analyzes how codon differences affect polypeptide sequences during translation. When position 5 contains different codons in the two mRNAs, different tRNAs will bind at that position, each delivering its specific amino acid (M for mRNA X, N for mRNA Y), resulting in polypeptides that differ by exactly one amino acid at position 5. All other positions remain identical because the codon sequences are the same, recruiting the same tRNAs and amino acids. Students choosing B incorrectly think ribosomes ignore codon differences, but the genetic code strictly determines which tRNA binds each codon. To predict polypeptide differences, compare codon sequences position by position and use the genetic code to determine amino acid changes.
In an in vitro translation reaction, tRNAs are charged with amino acids by aminoacyl-tRNA synthetases before entering the ribosome. A mutation reduces the ability of one synthetase to attach its amino acid to its specific tRNA, but the tRNA can still base-pair normally with its matching codon in the ribosome. Ribosomes, mRNA, and all other charged tRNAs are abundant. Which outcome is most likely for polypeptides produced from mRNAs containing that codon?
Explanation: This question tests understanding of how uncharged tRNAs affect translation elongation. When a specific aminoacyl-tRNA synthetase cannot charge its tRNA with the appropriate amino acid, that tRNA enters the ribosome without an amino acid attached. While the uncharged tRNA can still base-pair with its codon in the A site, it cannot donate an amino acid for peptide bond formation, causing the ribosome to stall at that position. Students choosing A incorrectly think a different amino acid would be incorporated, but synthetases are highly specific and other synthetases won't charge this tRNA. To analyze translation efficiency problems, consider whether all components (charged tRNAs, release factors, elongation factors) are functional at each step.
A researcher engineers an mRNA with a strong secondary structure (a stable hairpin) that forms within the coding region. The hairpin begins just after codon 6 and physically impedes ribosome movement along the mRNA, but it does not change the codon sequence itself. Initiation occurs normally at the start codon, and tRNAs are available. Which outcome is most likely for translation of this mRNA?
Explanation: This question tests understanding of how mRNA secondary structures affect ribosome movement. A stable hairpin structure in the mRNA creates a physical barrier that impedes the ribosome's translocation along the mRNA during elongation, causing translation to slow or pause when the ribosome encounters this structure around codon 6. The ribosome can eventually unfold the hairpin through its helicase activity, but this takes time and energy, reducing translation speed. Students choosing C incorrectly think RNA structures don't affect translation, confusing this with DNA replication, but ribosomes must physically move along mRNA and can be blocked by stable structures. To analyze translation efficiency, consider both the sequence information and physical accessibility of the mRNA.
In a bacterial cell, translation can begin on an mRNA while the mRNA is still being synthesized. A mutation changes the start codon AUG to AUC in an mRNA, but the rest of the coding region remains unchanged and contains no other start codons nearby. Assume the ribosome requires AUG to initiate efficiently at that site. Which outcome is most likely for translation of the mutated mRNA?
Explanation: This question tests understanding of translation initiation requirements. The initiator tRNA specifically recognizes the AUG start codon through complementary base pairing, and changing AUG to AUC prevents this recognition, greatly reducing or eliminating translation initiation at that site. Without proper initiation complex formation at the intended start site, the ribosome cannot begin elongation from the correct position. Students choosing A incorrectly think any codon can serve as a start codon, but prokaryotic and eukaryotic ribosomes specifically require AUG (occasionally GUG or UUG in bacteria) for efficient initiation. When analyzing translation efficiency, remember that initiation is a highly regulated step requiring specific sequences and factors.
An mRNA segment is translated by a ribosome that reads codons sequentially without overlapping. A student proposes that changing one nucleotide in the third position of a codon will always change the amino acid added. Another student notes that some different codons can be recognized by different tRNAs carrying the same amino acid, so a nucleotide change might recruit a tRNA with the same amino acid cargo. No stop codons are involved. Which outcome is most likely after a single-nucleotide substitution at the third base of one codon?
Explanation: This question analyzes the redundancy (degeneracy) of the genetic code. Many amino acids are encoded by multiple codons that differ only in the third position (wobble position), so a substitution at this position may recruit a different tRNA that carries the same amino acid, resulting in no change to the polypeptide sequence. For example, both UCU and UCC code for serine, so this third-position change wouldn't alter the protein. Students choosing A incorrectly think any base change must alter the amino acid, not understanding genetic code redundancy. When analyzing point mutations, check the genetic code table to determine whether the original and mutated codons encode the same or different amino acids.
A researcher compares translation of two mRNAs that differ only in the position of a stop codon. mRNA X: 5′-AUG AAA UAA GGG-3′. mRNA Y: 5′-AUG AAA GGG UAA-3′. In both cases, AUG recruits the initiator tRNA, and UAA is recognized by a release factor that triggers polypeptide release. The ribosome translates codons sequentially from 5′ to 3′ until it reaches a stop codon. Which outcome is most likely when comparing the two polypeptides?
Explanation: This question assesses the skill of analyzing translation processes in protein synthesis. The correct answer is A because mRNA X has the UAA stop codon earlier, after AUG and AAA, leading to termination and a shorter polypeptide compared to mRNA Y, where UAA is after an additional GGG codon. Both initiate at AUG with the initiator tRNA, but the ribosome translates sequentially until reaching the stop, releasing the chain via a release factor. This position difference results in mRNA Y producing a longer chain with an extra amino acid. A tempting distractor is B, which falsely claims mRNA X is longer due to UAA recruiting a tRNA, based on the misconception that stop codons add amino acids like regular codons. A transferable strategy is to count the codons between start and stop when comparing mRNAs, as stop position directly determines polypeptide length.
An mRNA is translated by a ribosome moving 5′ to 3′. A student writes that the amino acid sequence should be determined by reading the mRNA 3′ to 5′ because base pairing between codon and anticodon is antiparallel. In translation, each tRNA anticodon pairs antiparallel to an mRNA codon, but the ribosome advances along the mRNA one codon at a time in the 5′ to 3′ direction. Which explanation best accounts for why the student's prediction is incorrect?
Explanation: This question assesses the skill of analyzing translation processes in protein synthesis. The correct answer is A because the ribosome reads mRNA in the 5′ to 3′ direction, advancing one codon at a time, while each codon-anticodon pairing is antiparallel within that framework. This means the overall amino acid sequence is determined by the 5′ to 3′ codon order, not by reversing the reading direction. The student's error overlooks that antiparallel pairing occurs locally for each codon, but the ribosome's movement maintains the 5′ to 3′ progression. A tempting distractor is B, which falsely states ribosomes read 3′ to 5′ with stop codons, based on the misconception that directionality reverses under specific conditions. A transferable strategy is to visualize the ribosome's 5′ to 3′ movement along mRNA, integrating local antiparallel base pairing without altering the overall direction.
An mRNA contains the sequence 5′-AUG GAA CUA UAG-3′, where UAG is a stop codon. A researcher introduces a modified tRNA whose anticodon base-pairs with UAG and is charged with an amino acid. In normal cells, release factors bind stop codons and promote polypeptide release. Assume the modified tRNA competes successfully with the release factor at UAG. Which outcome is most likely for translation of this mRNA?
Explanation: This question assesses the skill of analyzing translation processes in protein synthesis. The correct answer is B because the modified tRNA base-pairs with the UAG stop codon and adds its charged amino acid, competing with the release factor and allowing translation to continue past UAG. Normally, stop codons like UAG trigger release factors for termination, but the suppressor tRNA enables read-through by incorporating an amino acid instead. This results in elongation proceeding beyond the intended stop, potentially extending the polypeptide if more codons follow. A tempting distractor is A, which incorrectly asserts termination occurs normally, based on the misconception that stop codons cannot pair with any anticodon even if a modified tRNA is present. A transferable strategy is to consider how alterations like suppressor tRNAs can override normal stop codon function, evaluating competition with release factors.
A mutation occurs in a tRNA gene such that the anticodon is altered, but the aminoacyl-tRNA synthetase still attaches the same amino acid to that tRNA as before. The altered anticodon now base-pairs with a different codon on mRNA. Ribosomes and mRNAs are otherwise normal. Which outcome is most likely in proteins translated in cells carrying this mutation?
Explanation: This question tests understanding of how tRNA mutations affect the genetic code. When a tRNA's anticodon mutates but the synthetase still charges it with the original amino acid, this tRNA will now deliver that same amino acid to a different codon position (wherever its new anticodon base-pairs). This creates a codon reassignment where the new codon now codes for the amino acid carried by the mutant tRNA instead of its normal amino acid. Students choosing A incorrectly think the mRNA codon directly determines amino acid identity, but amino acids are determined by which aminoacyl-tRNA binds the codon. To analyze tRNA mutations, consider both the anticodon change (affecting where it binds) and the synthetase specificity (affecting which amino acid it carries).
During translation, a ribosome reads an mRNA segment 5′-AUG GCU UAA-3′. A tRNA with an anticodon complementary to GCU delivers alanine. The AUG codon is recognized by an initiator tRNA carrying methionine, and UAA is a stop codon that is recognized by a release factor rather than a tRNA. The ribosome moves along the mRNA one codon at a time and forms peptide bonds between adjacent amino acids as matching tRNAs bind. Which outcome is most likely for the synthesized polypeptide?
Explanation: This question assesses the skill of analyzing translation processes in protein synthesis. The correct answer is A because translation initiates at the AUG codon with methionine, followed by the GCU codon delivering alanine via its complementary tRNA, forming a dipeptide. The ribosome then encounters the UAA stop codon, which is recognized by a release factor rather than a tRNA, leading to termination without adding another amino acid. This results in the release of the Met-Ala dipeptide, as the ribosome moves codon by codon, forming peptide bonds between adjacent amino acids. A tempting distractor is B, which incorrectly assumes UAA recruits a tRNA to insert a third amino acid, stemming from the misconception that stop codons encode amino acids like regular codons. A transferable strategy is to map out the codon sequence and recall that stop codons signal termination via release factors, not tRNA binding.
A ribosome translates an mRNA by matching codons with tRNA anticodons. A student writes an mRNA codon as 5′-AUG-3′ and proposes a tRNA anticodon written 5′-UAC-3′. In the ribosome, base pairing between codon and anticodon is antiparallel. The anticodon must align so that complementary bases pair correctly across the three positions. Which anticodon orientation is most likely to correctly pair with the codon 5′-AUG-3′ during translation?
Explanation: This question assesses the skill of analyzing translation by determining the correct orientation of a tRNA anticodon for base pairing with an mRNA codon. The mRNA codon 5′-AUG-3′ requires an anticodon that pairs antiparallel, meaning the anticodon is oriented 3′-UAC-5′ to allow complementary base pairing: A with U, U with A, and G with C. This antiparallel alignment ensures stable hydrogen bonding in the ribosome during codon-anticodon recognition. In contrast, writing the anticodon in the same 5′ to 3′ direction would not allow proper pairing, as the bases would not complement correctly. A tempting distractor is A, which proposes 5′-UAC-3′ because codon and anticodon pair in the same direction, but this is wrong due to the misconception that RNA strands pair parallel rather than antiparallel like DNA. When solving similar problems, always reverse the codon's orientation and apply complementary base rules to derive the anticodon sequence.
A ribosome translates an mRNA segment 5′-AUG CCC AAA GGG UAA-3′ in the shown reading frame. A mutation deletes the second nucleotide of the second codon, changing the sequence to 5′-AUG CCA AAG GGU AA-3′. Translation initiates at AUG and then continues by reading codons in the new frame until a stop codon is reached. No additional nucleotides are added, and the ribosome does not realign to the original frame. Which outcome is most likely for the mutant translation product?
Explanation: This question assesses the skill of analyzing translation by determining the effect of a single nucleotide deletion on the reading frame and polypeptide. Deleting the second nucleotide of the second codon shifts the grouping of all subsequent nucleotides, changing the codons from the original AUG-CCC-AAA-GGG-UAA to the new frame AUG-CCA-AAG-GGU-AA, potentially continuing until a new stop codon. This frameshift alters the amino acid sequence after the deletion point and may change the polypeptide length depending on when a stop codon appears in the new frame. Consequently, the mutant polypeptide sequence changes downstream of the deletion compared to the wild type. A tempting distractor is A, which claims the polypeptide is unchanged because deleting one nucleotide removes exactly one amino acid, but this is wrong due to the misconception that deletions affect only the immediate codon without shifting the frame. To solve similar deletion problems, regroup the nucleotides into codons starting from the start codon and compare the new sequence to identify frameshift effects and potential early or late stops.
A student compares two mRNAs translated in the same cytosol. mRNA 1 begins with AUG and has many codons before a stop codon. mRNA 2 lacks an AUG near its 5′ end but contains the same internal codons as mRNA 1. Translation requires an initiator tRNA to pair with a start codon to establish the reading frame, after which the ribosome matches tRNAs to codons sequentially. Which outcome is most likely for mRNA 2?
Explanation: This question assesses the skill of analyzing translation processes in protein synthesis. The correct answer is B because mRNA 2 lacks an AUG start codon near its 5′ end, making initiation unlikely as the initiator tRNA requires it to set the reading frame. Without proper initiation, the ribosome does not reliably begin translation, even if internal codons match those in mRNA 1. Translation on mRNA 1 proceeds normally from AUG to the stop codon, but mRNA 2's absence of a start prevents polypeptide synthesis. A tempting distractor is A, which falsely claims an identical polypeptide forms, arising from the misconception that internal codons can independently trigger initiation. A transferable strategy is to check for the presence and position of the start codon when comparing mRNAs, as it is crucial for establishing the translation reading frame.
A ribosome begins translating an mRNA that normally contains the codons 5′-AUG CCG GAA UGA-3′. In a mutant, the second codon changes from CCG to CCU. Both CCG and CCU are codons that can be matched by tRNAs carrying the same amino acid (proline), because different codons can specify the same amino acid. The start codon AUG still recruits the initiator tRNA, and UGA is still a stop codon recognized by a release factor. Which outcome is most likely for the polypeptide produced from the mutant mRNA?
Explanation: This question assesses the skill of analyzing translation processes in protein synthesis. The correct answer is B because both CCG and CCU code for proline due to the degeneracy of the genetic code, where multiple codons can specify the same amino acid via tRNAs. The mutation from CCG to CCU thus does not change the amino acid inserted at that position, and translation proceeds from the AUG start to the UGA stop, producing the same polypeptide sequence. The start codon still initiates with methionine, and the stop codon terminates normally, unaffected by the substitution. A tempting distractor is D, which wrongly suggests that only one codon specifies proline, based on the misconception that the genetic code lacks redundancy. A transferable strategy is to consult the genetic code table for codon-amino acid assignments when evaluating mutations, focusing on whether the change alters the specified amino acid.